A Dual-Fixed Neutrophil Substrate Improves Interpretation of Antineutrophil Cytoplasmic Antibodies by Indirect Immunofluorescence

Size: px
Start display at page:

Download "A Dual-Fixed Neutrophil Substrate Improves Interpretation of Antineutrophil Cytoplasmic Antibodies by Indirect Immunofluorescence"

Transcription

1 AJCP / Original Article A Dual-Fixed Neutrophil Substrate Improves Interpretation of Antineutrophil Cytoplasmic Antibodies by Indirect Immunofluorescence Ming-Wei Lin, MBBS, 1,2 Roger A. Silvestrini, 1 Suzanne Culican, 1 David Campbell, 1 and David A. Fulcher, MBBS, PhD 1,2 From the 1 Department of Immunopathology, Pathology West, ICPMR, Westmead Hospital, Westmead, Australia, and 2 Discipline of Medicine, Sydney Medical School, University of Sydney, Sydney, Australia. Key Words: Antineutrophil cytoplasmic antibody (ANCA); Vasculitis; Indirect immunofluorescence (IIF); Formalin fixation Am J Clin Pathol September 2014;142: DOI: /AJCPG02FGQVAUSIU ABSTRACT Objectives: To determine whether the addition of a formalinfixed neutrophil substrate could improve interpretation and prediction of autoantigenic specificity in antineutrophil cytoplasmic antibody (ANCA) testing. Methods: Routine diagnostic samples sent for ANCA testing were analyzed prospectively on a dual substrate of both ethanol- and formalin-fixed neutrophils. Positive samples on ethanol-fixed neutrophils were deemed typical if formalinfixed neutrophils also stained, and atypical if not. Indirect immunofluorescence (IIF) results were correlated with antimyeloperoxidase (MPO) and anti proteinase 3 (PR3) results with an enzyme-linked immunosorbent assay (ELISA). Results: Of 1,426 samples, 201 from unique patients were ANCA-positive (200 on IIF, 1 on ELISA alone). Thirty-two (45%) of 71 typical ANCA staining patterns were positive for either an anti-mpo or anti-pr3 antibodies, whereas only one (0.8%) of 129 atypical patterns was ELISA-positive, in a patient without systemic vasculitis. Only one (3%) of 34 ELISA-positive samples had a negative IIF-ANCA (1/1,426 patients, 0.07%), and this patient did not have vasculitis. Conclusions: Concomitant staining on formalin fixation of IIF-positive ethanol-fixed ANCA samples improves the interpretation of ANCA testing and is predictive of vasculitis autoantigens MPO and PR3. Detection of antineutrophil cytoplasmic antibodies (ANCA) is critical for the diagnosis and monitoring of the ANCA-associated vasculitides (AAVs), which include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pauci-immune crescentic glomerulonephritis, and Churg-Strauss syndrome (CSS, also called eosinophilic granulomatosis with polyangiitis or allergic granulomatosis). The test is usually performed with indirect immunofluorescence (IIF) using alcohol-fixed neutrophils as substrate, where the pattern of cytoplasmic staining has distinct diagnostic implications. Traditionally defined, cytoplasmic ANCA (c-anca), characterized by diffuse granular cytoplasmic staining with internuclear accentuation Image 1, is associated with anti proteinase 3 (PR3) antibodies, a specificity typical of GPA but also found in other AAVs. Similarly, a perinuclear ANCA (p-anca) gives rise to homogeneous perinuclear staining with nuclear extension (Image 1); this pattern occurs due to the relocation of negatively charged cytoplasmic autoantigens to the nuclear membrane upon alcohol fixation. It often reflects the presence of antimyeloperoxidase (MPO) antibodies, and is associated with various AAVs, particularly MPA, pauci-immune crescentic glomerulonephritis, and CSS. Subsequent to the description of these typical patterns, so-called atypical patterns were recognized. Although interpretations vary, a dull, flat, diffuse cytoplasmic staining without central accentuation is often reported as atypical c-anca (Image 1), whereas a broad pencillike perinuclear staining with no nuclear extension is often termed atypical p-anca (Image 1). The recognition of atypical patterns is important, because the target autoantigens that give rise to them are different and not associated with Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU 325

2 Lin et al / Dual-Fixed Neutrophil Substrate for ANCA Testing Image 1 The four antinuclear cytoplasmic antibody (ANCA) fluorescence patterns based on staining of ethanol- and formalinfixed neutrophils, as indicated, including cytoplasmic ANCA (c-anca), perinuclear ANCA (p-anca), atypical c-anca, and atypical p-anca Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU

3 AJCP / Original Article vasculitis. They include lactoferrin, cathepsin G, elastase, lysozyme, bacterial permeability increasing protein, catalase, α-enolase, and lamin B1. 1 Such specificities are much less useful diagnostically, being found in various conditions including inflammatory bowel disease (IBD), 1 rheumatoid arthritis, Felty syndrome, primary sclerosing cholangitis, chronic bacterial infections, 2,3 and chronic liver disease. 4 However, distinguishing typical from atypical ANCA patterns is not straightforward, a difficulty that gives rise to significant discrepancies among laboratories in regard to interpretive criteria and reporting schemata. Interpretation may also be affected by interference from concomitant homogeneous ANA, which may mimic and therefore mask the presence of an underlying p-anca. To improve interpretation of IIF-ANCA patterns, several groups have proposed that concomitant consideration of the staining pattern on formalin-fixed neutrophils, in addition to the standard ethanol fixation, may be helpful Despite initial enthusiasm for this approach, other studies have identified inconsistencies, including false positivity owing to enhanced autofluorescence on the formalin-fixed substrate Given these controversies, the selective nature of the cohorts examined in these studies and the paucity of reports correlating IIF-ANCA patterns on a dual substrate with autoantigenic specificity, we examined the latter approach to ANCA testing in the routine diagnostic laboratory. 2. p-anca: Homogeneous perinuclear staining with nuclear extension on ethanol-fixed neutrophils, but a classic c-anca pattern (above) on formalin-fixed neutrophils (Image 1); 3. Atypical c-anca: Dull homogeneous cytoplasmic fluorescence without central accentuation on ethanolfixed neutrophils, but no fluorescence on formalin-fixed neutrophils (Image 1); 4. Atypical p-anca: Broad rim-like fluorescence of the nuclear periphery without nuclear extension on ethanolfixed neutrophils, but no fluorescence on formalin-fixed neutrophils (Image 1). The IIF-ANCA patterns were interpreted by two independent readers (R.A.S. and either S.C. or D.C.), who were blinded to the enzyme-linked immunosorbent assay (ELISA) results. ELISA Anti-MPO and -PR3 antibodies were detected using a commercial ELISA (INOVA Diagnostics, Werfen Group, Barcelona, Spain), performed according to the manufacturer s instructions. An anti-pr3 antibody result greater than 5 U/mL and anti-mpo antibody greater than 10 U/mL was considered positive. Results Materials and Methods Specimens Specimens were collected between February and July 2012 from diagnostic samples referred for ANCA testing to the immunopathology laboratory of the Institute of Clinical Pathology and Medical Research, Pathology West, Westmead Hospital, Sydney, Australia, a diagnostic laboratory servicing about one-quarter of public pathology in New South Wales, Australia. For patients with multiple ANCA requests over this time, only the first sample was included in the analysis. ANCA Interpretation IIF was performed using a combination of two substrates in a single well (Euroimmun Mosaic ANCA Biochip, ESL Biosciences, Lübeck, Germany), including ethanol- and formalin-fixed neutrophils. Samples were screened at 1/10 dilution, and four patterns were distinguished based on individual staining patterns, as follows: 1. c-anca: Finely granular diffuse fluorescence present throughout the cytoplasm with central accentuation, with similar appearance on ethanol- and formalin-fixed neutrophils (Image 1); The study included 1,426 unique patient samples, of which 200 were IIF-ANCA positive. Of these, 35 (18%) were c-anca, 36 (18%) were p-anca, 33 (17%) atypical c-anca, and 96 (48%) atypical p-anca Table 1. Positivity for anti-pr3 or anti-mpo by ELISA was almost completely restricted to the samples showing typical ANCA staining patterns on IIF. Thus, of the 35 c-anca samples, 17 (49%) were positive for anti-pr3, anti-mpo, or both (Table 1), and of the 36 p-anca positive samples, 15 (42%) were positive for one of these two specificities. Importantly, only one (0.8%) of 129 samples with an atypical IIF-ANCA pattern was positive on ELISA. This patient had an atypical p-anca on IIF, a low positive anti-pr3 level of 16 U/mL, but no clinical or radiologic evidence of vasculitis. The close correlation between typical ANCA staining patterns and autoantigenic specificity on ELISA prompted us to question whether IIF screening alone was able to detect all vasculitis-associated specificities, a finding that would allow testing for autoantigenic specificity to be reserved for those showing typical ANCA-IIF patterns. Consistent with this, only one (3%) of 34 ELISA-positive samples (1/1,426 [0.07%]) was negative on fluorescence. This sample was positive for both anti-mpo and anti-pr3 antibodies (both >100 U/mL); the patient had a clinical history of chronic Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU 327

4 Lin et al / Dual-Fixed Neutrophil Substrate for ANCA Testing Table 1 Summary of the IIF-ANCA Pattern and ELISA Results Anti-PR3+/Anti-MPO+ IIF-ANCA Pattern No. of Patients Anti-PR3+ Anti-MPO+ Dual Specificity Negative PR3 and MPO c-anca p-anca Atypical c-anca Atypical p-anca Negative 1, ,225 ANCA, antinuclear cytoplasmic antibody; c-anca, cytoplasmic ANCA; ELISA, enzyme-linked immunosorbent assay; IIF, indirect immunofluorescence; MPO, myeloperoxidase; p-anca, perinuclear ANCA; PR3, proteinase 3. osteomyelitis with no evidence of systemic vasculitis, suggesting a false-positive result. Discussion ANCA testing is central to the diagnosis and classification of vasculitic diseases, yet the interpretation of IIF patterns based on a single substrate of ethanol-fixed neutrophils alone can be problematic in terms of distinguishing typical from atypical ANCA patterns, and in addressing interference from antinuclear antibodies. However, given the major differences in diagnostic implications, this distinction is important. Here we demonstrate that such differentiation can readily be made by considering IIF-ANCA staining patterns on formalinfixed, alongside ethanol-fixed, neutrophils. By defining a typical pattern as being positive on both substrates, we found a strong association with antibodies to PR3 and MPO, and by inference, with likelihood of AAV. 14,15 At the same time, atypical IIF-ANCA samples, defined as being positive on ethanol- but negative on formalin-fixed neutrophils, had a very low (<1%) positivity rate for anti-pr3 or anti- MPO antibodies in our study (Table 1), making a diagnosis of AAV much less likely. Widespread adoption of this approach would not only improve diagnostic accuracy, but also minimize intra- and interlaboratory variation, given its relatively straightforward interpretation by comparison with the often subtly different staining patterns on a single ethanolfixed neutrophil slide. Furthermore, the use of formalin-fixed neutrophils overcomes the problem of interference from antinuclear antibodies, which give a p-anca pattern on the ethanol-fixed neutrophil substrate, but are negative on formalin-fixed neutrophils. 6,16,20 Finally, given the confusion surrounding the various definitions of what constitutes a typical vs atypical IIF-ANCA pattern, 5,17 an argument could be made for abandoning the term atypical completely, and replacing it with a term such as nonspecific ANCA, with the potential to cause less confusion in diagnostic interpretation. Other researchers have previously examined the use of formalin fixation in differentiating the IIF-ANCA patterns. 6,8,11-13,18-21 Results have been highly variable, possibly because of differences in methodology, such as variable incubation times, concomitant use of acetone, different types of formalin (vapor vs liquid), and different types of alcohol fixative (ethanol vs methanol). Only five studies, performed in very selected patient populations, have specifically addressed the issue of PR3 and MPO specificity in relation to the use of formalin-fixed neutrophils, 8,11,16,20,21 and generated results consistent with those reported here in our otherwise unselected cohort. Radice et al 8 studied serum samples selected on the basis of disease and antigenic specificity, and found that samples from patients with vasculitis who were positive for anti-pr3 or anti-mpo antibodies were the only ones to show ANCA staining on formalin-fixed neutrophils, whereas serum samples from patients with ulcerative colitis did not. Similarly, studies by Lee et al 20 and Bang la Cour et al 11 also demonstrated that anti-mpo positive samples could readily be detected on formalin-fixed neutrophils. Pollock et al 21 selected patients with MPA and compared them with those with IBD or lupus, and found perfect correlation between those with active MPA and both ANCA staining on formalin-fixed neutrophils and MPO positivity; however, in those with vasculitis who received treatment, the MPO appeared to be slightly more sensitive. Finally, Damoiseaux et al 16 examined the usefulness of the Europlus ANCA Biochip mosaic, incorporating a substrate of both formalin- and ethanol-fixed neutrophils alongside PR3 and MPO antigen microdots, in a cohort of patients with AAV. Consistent with our results, they found a high correlation (>96%) between typical IIF-ANCA patterns and positivity for PR3 or MPO; furthermore, all IIF-ANCA samples that were negative on a formalin-fixed substrate were also negative for anti-mpo and anti-pr3. Although our study lacked clinical information on the samples studied, we showed that in the diagnostic laboratory environment, processing otherwise unselected patient samples, positivity on formalin-fixed neutrophils was very predictive of positivity for the two major vasculitis-associated antigens. Our study has deliberately focused on the detection of the vasculitis-associated specificities PR3 and MPO, fully 328 Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU

5 AJCP / Original Article recognizing that IIF-ANCA is also occasionally used for the diagnosis of nonvasculitic diseases. For example, in IBD, IIF-ANCA patterns can help differentiate ulcerative colitis from Crohn disease, usually in conjunction with anti- Saccharomyces cerevisiae antibodies; thus patients with ulcerative colitis are usually negative for anti-s cerevisiae antibodies but have atypical p-anca, whereas patients with Crohn disease often have the opposite serologic findings. Although we did not examine patients with IBD specifically, the use of a dual substrate to define an atypical IIF-ANCA pattern in the manner outlined in our study should not detract from the usefulness of IIF-ANCA for this purpose. Indeed, a recent study showed that the distinction between typical and atypical p-anca using formalin fixation improved the sensitivity and specificity of ANCA testing in a cohort of 184 patients with IBD 1 ; MPO specificity was not reported, but seems unlikely to be relevant given the nature of the cohort. Finally, our study had significant implications for the optimal cost-effective approach for detecting and characterizing serum samples referred for ANCA testing. Although current international guidelines recommend that all serum samples be tested using IIF along with immunoassays for PR3 and MPO, 5 our data support the contention that ELISA testing could be restricted to samples showing a typical ANCA on IIF. Thus, only one ELISA-positive sample of our 1,426 referred samples (or 1/34 ANCA-positive samples) would have been missed with such an approach, and this patient did not have vasculitis. Our findings therefore have significant cost implications for laboratories, particularly given the large number of patients now being screened for ANCA. We propose that the term typical ANCA be used to refer to dual staining on both ethanol- and formalin-fixed neutrophil substrates, divided into c-anca and p-anca based on the ethanol-fixed slide (Image 1). All other neutrophil staining patterns could be reported as nonspecific ANCA, because they are rarely associated with PR3 or MPO specificity and thus unlikely to convey a diagnosis of vasculitis. Our laboratory now adopts this reporting schema. Reprint requests to Dr Lin: Dept of Immunopathology, Pathology West, ICPMR, Westmead Hospital, Westmead, New South Wales 2145, Australia; ming-wei.lin@sydney.edu.au. References 1. Barahona-Garrido J, Hernandez-Calleros J, Cabiedes J, et al. Distinguishing between anti-neutrophil cytoplasmic antibody patterns in inflammatory bowel disease: is the atypical pattern adding more information? Am J Gastroenterol. 2009;104: Bonaci-Nikolic B, Andrejevic S, Pavlovic M, et al. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheumatol. 2010;29: Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infectioninduced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol. 2010;22: Wong RC, Silvestrini RA, Savige JA, et al. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. J Clin Pathol. 1999;52: Savige J, Gillis D, Benson E, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999;111: Lock RJ. ACP Broadsheet No 143: January 1994 detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol. 1994;47: Papp M, Altorjay I, Lakos G, et al. Evaluation of the combined application of ethanol-fixed and formaldehydefixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Clin Vaccine Immunol. 2009;16: Radice A, Vecchi M, Bianchi MB, et al. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies: the role of different fixatives. Clin Exp Rheumatol. 2000;18: Bird AG. Is there life in the formalin fixed neutrophil for ANCA testing? no! J Clin Pathol. 1999;52: Terjung B, Worman HJ, Herzog V, et al. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-anca) using immunofluorescence microscopy. Clin Exp Immunol. 2001;126: Bang la Cour B, Wiik A, Hoier-Madsen M, et al. Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity: a methodological study. J Immunol Methods. 1995;187: Chowdhury SM, Broomhead V, Spickett GP, et al. Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J Clin Pathol. 1999;52: Spickett GP, Broomhead V. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Pathol. 1995;48: van der Woude FJ. Anticytoplasmic antibodies in Wegener s granulomatosis. Lancet. 1985;2: Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318: Damoiseaux J, Steller U, Buschtez M, et al. EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods. 2009;348: Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU 329

6 Lin et al / Dual-Fixed Neutrophil Substrate for ANCA Testing 17. Savige J, Dimech W, Fritzler M, et al. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies: quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol. 2003;120: Yang P. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence. J Clin Pathol. 1997;50: Billing P, Tahir S, Calfin B, et al. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol. 1995;147: Lee SS, Lawton JW, Chak W. Distinction between antinuclear antibody and P-ANCA. J Clin Pathol. 1991;44: Pollock W, Trevisin M, Savige J. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs. J Immunol Methods. 2008; 339: Am J Clin Pathol 2014;142: DOI: /AJCPG02FGQVAUSIU

Diagnostic Value of Distinguishing and Reporting Different Perinuclear ANCA (P-ANCA) Immunofluorescence Patterns A Prospective Study

Diagnostic Value of Distinguishing and Reporting Different Perinuclear ANCA (P-ANCA) Immunofluorescence Patterns A Prospective Study Diagnostic Value of Distinguishing and Reporting Different Perinuclear ANCA (P-ANCA) Immunofluorescence Patterns A Prospective Study CME/SAM Susan B. Perel, MBBS, FRACP, FRCPA, 1,2 Kerri M. Prain, 1 Robert

More information

Abstract. Immunopathology / ADDENDUM TO CONSENSUS STATEMENT ON TESTING AND REPORTING OF ANCA

Abstract. Immunopathology / ADDENDUM TO CONSENSUS STATEMENT ON TESTING AND REPORTING OF ANCA Immunopathology / ADDENDUM TO CONSENSUS STATEMENT ON TESTING AND REPORTING OF ANCA Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies Quality

More information

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link EDITORIAL, October 2004 Welcome to the Spring 2004 Edition of InfoLink. The feature article in this edition has been written by Dr Rodger Laurent, Head of Department, PaLMS Rheumatology Laboratory. The

More information

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns 124 Immunopathology Department, ICPMR, Westmead Hospital, NSW 2145, Australia RCWWong R A Silvestrini D A Fulcher E M Benson University Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg,

More information

A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their diverentiation from other antibodies

A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their diverentiation from other antibodies 568 J Clin Pathol 1998;51:568 575 Papers University Medicine, Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia J A Savige Biochemistry, St Vincent s Hospital, Fitzroy, Victoria,

More information

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin

More information

EliA MPO S and EliA PR3 S

EliA MPO S and EliA PR3 S Edition 1 2011 n Review ANCA and associated diseases n The Assays EliA MPO S and EliA PR3 S n Experience ANCA testing by high sensitive methods CONTENTS Editorial Some months ago a Swiss colleague sent

More information

Comparative Study of ELISA and Indirect Immunofluorescence for the Detection of Anti-Neutrophil Cytoplasmic Antibodies

Comparative Study of ELISA and Indirect Immunofluorescence for the Detection of Anti-Neutrophil Cytoplasmic Antibodies IMMUNOPATHOLOGY Comparative Study of ELISA and Indirect Immunofluorescence for the Detection of Anti-Neutrophil Cytoplasmic Antibodies Evaluation of the SCIMEDX/EURO Diagnostica ELISA Assay in a Clinical

More information

International Consensus Statement on Testing and

International Consensus Statement on Testing and I m m u n o p a t h o l o g y / TESTING FOR A N C A S International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Key Words: ANCA; Autoantibodies; Glomerulonephritis;

More information

International Consensus Statement on Testing and

International Consensus Statement on Testing and I m m u n o p a t h o l o g y / TESTING FOR A N C A S International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Judy Savige, MB, PhD, David Gillis, MB,

More information

NOVA Lite ANCA (Ethanol) Kit with DAPI For In Vitro Diagnostic Use CLIA Complexity: High

NOVA Lite ANCA (Ethanol) Kit with DAPI For In Vitro Diagnostic Use CLIA Complexity: High Format to CLSI Standards GP2-A5 (Formerly NCCLS) Vol. 26 No. 12 Issue Date: 09/11/13 NOVA Lite ANCA (Ethanol) 708301 Kit with DAPI For In Vitro Diagnostic Use CLIA Complexity: High Principles of the Procedure

More information

VASCULITIS PRODUCT HIGHLIGHTS

VASCULITIS PRODUCT HIGHLIGHTS VASCULITIS PRODUCT HIGHLIGHTS AESKU.DIAGNOSTICS offers a comprehensive and complete diagnostic portfolio in the field of vasculitis diagnostics. Not only are screening and profiling s available but also

More information

4. KIDNEYS AND AUTOIMMUNE DISEASE

4. KIDNEYS AND AUTOIMMUNE DISEASE How to Cite this article: Kidneys and Autoimmune Disease - ejifcc 20/01 2009 http://www.ifcc.org 4. KIDNEYS AND AUTOIMMUNE DISEASE Maksimiljan Gorenjak 4.1 Autoimmune diseases The human immune system limits

More information

LABORATORY STANDARD IN THE DIAGNOSIS AND THERAPY MONITORING OF AUTOIMMUNE DISEASE: VASCULITIS

LABORATORY STANDARD IN THE DIAGNOSIS AND THERAPY MONITORING OF AUTOIMMUNE DISEASE: VASCULITIS LABORATORY STANDARD IN THE DIAGNOSIS AND THERAPY MONITORING OF AUTOIMMUNE DISEASE: VASCULITIS Prof. Branko Malenica, Ph.D. Division of Immunology and Reference Center for Laboratory Immunodiagnosis of

More information

PR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening

PR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening PR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening Stephen Holding PhD FRCPath Consultant Clinical Scientist Hull & East Yorkshire Hospitals steve.holding@hey.nhs.uk

More information

Chapter 2 Animal Models of ANCA-Associated Vasculitides

Chapter 2 Animal Models of ANCA-Associated Vasculitides Chapter 2 Animal Models of ANCA-Associated Vasculitides Domenico Ribatti and Franco Dammacco Abstract Antibodies against neutrophil proteins myeloperoxidase (MPO) and proteinase- 3 (PR3) are responsible

More information

Assays. New. New. Combinations. Possibilities. Patents: EP , AU

Assays. New. New. Combinations. Possibilities. Patents: EP , AU Assays Patents: EP 2362222, AU 2011217190 New Combinations New Possibilities Technology Classical Handling of Autoimmune Diagnostics 2-Step Diagnostics 1 st Screening 2 nd Confirmation Cell based IFA ELISA

More information

ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TESTING GUIDELINES

ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TESTING GUIDELINES ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TESTING GUIDELINES Version: 1.0 Ratified by: Clinical Biochemistry Senior Staff Group Date ratified: Name of originator/author: Director responsible for implementation:

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Banff- Rocky Mountain Barry Kassen, MD, FRCPC,FACP Head, Division of Internal Medicine UBC/VGH/SPH Acting Head, Division of Community Internal Medicine November, 2009 Objectives 1. To understand small

More information

Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies

Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies Autoimmune diagnostics A comprehensive product line for the detection of autoantibodies Autoimmune diagnostics Autoimmune diseases are chronic inflammatory processes with an indeterminate etiology. They

More information

A historical essay on detection of anti-neutrophil cytoplasmic antibodies

A historical essay on detection of anti-neutrophil cytoplasmic antibodies Nephrol Dial Transplant (2015) 30: i8 i13 doi: 10.1093/ndt/gfv070 NDT Perspectives A historical essay on detection of anti-neutrophil cytoplasmic antibodies Niels Rasmussen 1, Allan Wiik 1 and David R.

More information

Simultaneous comprehensive multiplex autoantibody analysis by CytoBead technology for Rapidly Progressive Glomerulonephritis.

Simultaneous comprehensive multiplex autoantibody analysis by CytoBead technology for Rapidly Progressive Glomerulonephritis. Simultaneous comprehensive multiplex autoantibody analysis by CytoBead technology for Rapidly Progressive Glomerulonephritis l Assays Indirect Immunofluorescence Goldstandard for Diagnosis of Autoimmune

More information

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS GRANULOMATOSIS WITH POLYANGIITIS (GPA), MICROSCOPIC POLYANGIITIS (MPA), and EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS What is ANCA-associated Vasculitis?

More information

Antineutrophil Cytoplasmic Antibodies in Patients with Pulmonary Tuberculosis

Antineutrophil Cytoplasmic Antibodies in Patients with Pulmonary Tuberculosis SHORT PAPER Antineutrophil Cytoplasmic Antibodies in Patients with Pulmonary Tuberculosis Roya Sherkat*, Kamyar Mostafavizadeh, Lale Zeydabadi, Parisa Shoaei, Sodabeh Rostami Isfahan University of Medical

More information

University of Groningen

University of Groningen University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt, Xavier; Tervaert, Jan-Willem Cohen; Arimura, Yoshihiro;

More information

antigens co-expressed on granulocytes as well as other leukocyte populations are most often anti-hla class I antibodies. Antigen system Polymorphism Old terminology Location Antigen frequency in Europeans

More information

Medical Policy Title: Serum Antibodies for ARBenefits Approval: 10/12/11

Medical Policy Title: Serum Antibodies for ARBenefits Approval: 10/12/11 Medical Policy Title: Serum Antibodies for ARBenefits Approval: 10/12/11 Diagnosis of Inflammatory Bowel Disease Effective Date: 01/01/2012 Document: ARB0314 Revision Date: Code(s): 83516 Immunoassay for

More information

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease Inflammatory Bowel Disease Experts in Autoimmunity Inova Diagnostics offers a complete array of methods to aid in the diagnosis

More information

Clinical audit. An audit of ANCA in routine clinical practice. JDM Edgar, SA McMillan, IN Bruce, SK Conlan. biochemical, radiological, and

Clinical audit. An audit of ANCA in routine clinical practice. JDM Edgar, SA McMillan, IN Bruce, SK Conlan. biochemical, radiological, and Postgrad Med J 1995; 71: 605-612 C The Fellowship of Postgraduate Medicine, 1995 Clinical audit Department of Immunology, Queen's Medical Centre, Nottingham, NG7 2UH, UK JDM Edgar Regional Immunology Laboratory,

More information

Citation for published version (APA): Chen, M. (2009). Pathogenetic and clinical aspects of ANCA-associated vasculitis Groningen: s.n.

Citation for published version (APA): Chen, M. (2009). Pathogenetic and clinical aspects of ANCA-associated vasculitis Groningen: s.n. University of Groningen Pathogenetic and clinical aspects of ANCA-associated vasculitis Chen, Min IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

Methodological update How and why should we detect ANCA?

Methodological update How and why should we detect ANCA? Clinical and Experimental Rheumatology 2000; 18: 000-000. Methodological update How and why should we detect ANCA? CASE REPORT M. Segelmark, K. Westman, J. Wieslander 1 Department of Nephrology, University

More information

Antineutrophil Cytoplasmic Antibodies: Historical perspectives and new advances

Antineutrophil Cytoplasmic Antibodies: Historical perspectives and new advances INOVA NEWS Antineutrophil Cytoplasmic Antibodies: Historical perspectives and new advances First described in 1982, antineutrophil cytoplasmatic antibodies (ANCA) represent a diagnostically important group

More information

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston, MA Diagnostic Tests in Rheumatic Disease: What's Old,

More information

ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis GUIDELINES

ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis GUIDELINES NEPHROLOGY 2008; 13, S17 S23 ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis Date written: June 2007 Final submission: October 2007 Author: Grant Luxton, Robyn Langham

More information

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) J. Charles Jennette Ronald J. Falk The kidneys are affected by a variety of systemic vasculitides

More information

anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide, corticosteroid

anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide, corticosteroid Online publication June 24, 2009 ANCA JMAAV 1 2 ANCA JMAAV MPO-ANCA 18 17 50 J Jpn Coll Angiol, 2009, 49: 53 61 anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide,

More information

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) AND SMALL VESSEL VASCULITIS

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) AND SMALL VESSEL VASCULITIS ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) AND 193 Case report ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) AND P. Mareen, S. Van De Walle, P. Bernaert, H. Vanhouteghem, J. Dierick Keywords: Wegener

More information

Screening of Auto Antibodies using Indirect Immunofluorescence in Auto Immune Disease Patients

Screening of Auto Antibodies using Indirect Immunofluorescence in Auto Immune Disease Patients International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 02 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.702.386

More information

Anti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease

Anti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease Anti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease Grace M. Lee, Yara A. Park, Marshall Mazepa, Jay S. Raval Introduction Anti-neutrophil

More information

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Vasculitis Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Disease Spectrum Hypersensitivity vasculitis/microscopic

More information

Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease

Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease A.J. Russo 1, A Krigsman 2, B Jepson 2 and Andrew Wakefield 2 ORIGINAL RESEARCH 1 Science Department, Mount Saint Mary s University,

More information

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth SHO Teaching Vasculitis Renal medicine Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth OUTLINE What is vasculitis Causes Classification Brief look into ANCA Associated Vasculitis (AAV)

More information

Antibodies to selected minor target anti-neutrophil cytoplasmic antigens in systemic lupus patients

Antibodies to selected minor target anti-neutrophil cytoplasmic antigens in systemic lupus patients Original Article Antibodies to selected minor target anti-neutrophil cytoplasmic antigens in systemic * MBChB, FIBM immunology Fac Med Baghdad 25; Vol.5, No.3 Received:March,25 Accepted: May,25 Introduction:

More information

Target Antigens for Perinuclear Antineutrophil Cytoplasmic Antibodies in Iranian Patients with Ulcerative Colitis

Target Antigens for Perinuclear Antineutrophil Cytoplasmic Antibodies in Iranian Patients with Ulcerative Colitis Original Article 203 Target Antigens for Perinuclear Antineutrophil Cytoplasmic Antibodies in ian Patients with Ulcerative Colitis Ali Bahari 1*, Mahmoud Aarabi 2,3, Mehdi Hedayati 4, Ali Jarollahi 5,

More information

Anti-Nuclear Antibodies (ANA). (Incorporating Anti-double stranded DNA (dsdna) and Anti-Extractable Nuclear Antigen (ENA) Antibodies)

Anti-Nuclear Antibodies (ANA). (Incorporating Anti-double stranded DNA (dsdna) and Anti-Extractable Nuclear Antigen (ENA) Antibodies) Autoimmune Antibody Testing Points of Note: The interpretation of all autoantibody tests is highly dependent on the likelihood of disease in the patient. The results should always be interpreted with the

More information

J Sobajima, S Ozaki, H Uesugi, F Osakada, M Inoue, Y Fukuda, H Shirakawa, M Yoshida, A Rokuhara, H Imai, K Kiyosawa, K Nakao

J Sobajima, S Ozaki, H Uesugi, F Osakada, M Inoue, Y Fukuda, H Shirakawa, M Yoshida, A Rokuhara, H Imai, K Kiyosawa, K Nakao Gut 1999;44:867 873 867 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan J Sobajima S Ozaki H Uesugi M

More information

Anti-neutrophil Cytoplasmic Antibody-associated Pauci-immune Crescentic Glomerulonephritis Complicating Sjögren s Syndrome

Anti-neutrophil Cytoplasmic Antibody-associated Pauci-immune Crescentic Glomerulonephritis Complicating Sjögren s Syndrome Volume 110 Number 7 July 2011 Enterovirus 71 vaccine: When will it be available? GRP78 in embryonic development and neurological disorders Directly observed therapy for Tuberculosis patients in Taiwan

More information

V asculitis is an inflammatory process of blood vessels,

V asculitis is an inflammatory process of blood vessels, 723 ORIGINAL ARTICLE Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre

More information

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Annual Rheumatology & Therapeutics Review for Organizations & Societies Annual Rheumatology & Therapeutics Review for Organizations & Societies Update on Granulomatosis with Polyangiitis (Wegener s) Learning Objectives Identify the clinical features of granulomatosis with

More information

Inflammatory bowel disease with cytoplasmic-staining. antineutrophil cytoplasmic antibody and extensive colitis.

Inflammatory bowel disease with cytoplasmic-staining. antineutrophil cytoplasmic antibody and extensive colitis. ORIGINAL ARTICLE Inflammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis Hugh James Freeman MD HJ Freeman. Inflammatory bowel disease with cytoplasmicstaining

More information

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis Kidney International, Vol. 53 (1998), pp. 743 753 Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis E. CHRISTIAAN HAGEN, MOHAMED R. DAHA,

More information

Vasculitis of the peripheral nervous system

Vasculitis of the peripheral nervous system 4 rd Congress of the European Academy of Neurology Lisbon, Portugal, June 16-19, 2018 Teaching Course 5 Acute emergencies in neuromuscular disease - Level 2 Vasculitis of the peripheral nervous system

More information

Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis

Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis Rheumatology 2008;47:1515 1520 Advance Access publication 1 August 2008 doi:10.1093/rheumatology/ken321 Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated

More information

Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases

Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases Kidney International, Vol. 65 (2004), pp. 2145 2152 Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases MARK HAAS and JOSEPH A. EUSTACE Department of Pathology

More information

Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease

Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease Article Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease JulieAnne G. McGregor, Susan L. Hogan, Yichun Hu, Caroline E. Jennette, Ronald J. Falk, and Patrick

More information

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18 Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Thyroid Peroxidase (TPO) Antibody 5.0 IU/mL [0.0-9.0] 18-289-900139 16-Oct-18 Complement Component 3 50 mg/dl 18-289-900139

More information

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis Edward Dwyer, M.D. Division of Rheumatology VASCULITIS is a primary inflammatory disease process of the vasculature Determinants of the Clinical Manifestations of : Target organ involved Size of vessel

More information

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS British Journal of Rheumatology 1996;35:38-43 ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS M. DE BANDT, O. MEYER, T. HAIM ind M.-F. KAHN Laboratory of Immuno-Rheumatology, Bichat

More information

VASCULITIS. Case Presentation. Case Presentation

VASCULITIS. Case Presentation. Case Presentation VASCULITIS Case Presentation The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

Monitoring Proteinase 3 Antineutrophil Cytoplasmic Antibodies for Detection of Relapses in Small Vessel Vasculitis

Monitoring Proteinase 3 Antineutrophil Cytoplasmic Antibodies for Detection of Relapses in Small Vessel Vasculitis CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2003, p. 769 774 Vol. 10, No. 5 1071-412X/03/$08.00 0 DOI: 10.1128/CDLI.10.5.769 774.2003 Copyright 2003, American Society for Microbiology. All Rights

More information

Review Article Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies

Review Article Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies Journal of Immunology Research, Article ID 185416, 12 pages http://dx.doi.org/10.1155/2014/185416 Review Article Novel Clinical and Diagnostic Aspects of Antineutrophil Cytoplasmic Antibodies Johannes

More information

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH Emergent Rheumatologic Diseases and Disorders for Primary Care. The Power of the ANA April 2018 Emily Littlejohn, DO MPH Question 1: the ANA test is: A) A screening test with high specificity to diagnose

More information

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Tell me more about vasculitis Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Talk overview Case study ANCA-associated vasculitis What is ANCA vasculitis? What causes ANCA

More information

Rhematologic serum testing is: Before request serologic tests, ANCA associated antigens c-anca: most commonly against the proteinase 3 (PR-3)

Rhematologic serum testing is: Before request serologic tests, ANCA associated antigens c-anca: most commonly against the proteinase 3 (PR-3) thorough P/E. Rhematologic serum testing is: Useful to confirm a clinical impression or sort out a differential diagnosis Not useful as a screening test A positive test may or may not be associated with

More information

Citation for published version (APA): Chen, M. (2009). Pathogenetic and clinical aspects of ANCA-associated vasculitis Groningen: s.n.

Citation for published version (APA): Chen, M. (2009). Pathogenetic and clinical aspects of ANCA-associated vasculitis Groningen: s.n. University of Groningen Pathogenetic and clinical aspects of ANCA-associated vasculitis Chen, Min IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

Scleritis LEN V KOH OD

Scleritis LEN V KOH OD Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

Publication of the Month 2003

Publication of the Month 2003 Publication of the Month 2003 Issue 12/2003 Issue 11/2003 Issue 10/2003 Issue 9/2003 Issue 8/2003 Issue 7/2003 Issue 6/2003 Issue 5/2003 Issue 4/2003 Issue 3/2003 Issue 2/2003 Issue 1/2003 Autoantibodies

More information

Anti-neutrophil antibodies in inflammatory bowel

Anti-neutrophil antibodies in inflammatory bowel 668 Department of Renal Medicine, Institute of Urology, University College and Middlesex School of Medicine, London, WI G Cambridge B Leaker Department of Gastroenterology, The Royal London Hospital, London

More information

Complement in vasculitis and glomerulonephritis. Andy Rees Clinical Institute of Pathology Medical University of Vienna

Complement in vasculitis and glomerulonephritis. Andy Rees Clinical Institute of Pathology Medical University of Vienna Complement in vasculitis and glomerulonephritis Andy Rees Clinical Institute of Pathology Medical University of Vienna 41 st Heidelberg Nephrology Seminar March 2017 The complement system An evolutionary

More information

Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis

Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis NDT Advance Access published March 26, 2006 Nephrol Dial Transplant (2006) 1 of 8 doi:10.109/ndt/gfl097 Original Article Persistent T-cell activation and clinical correlations in patients with ANCA-associated

More information

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 12 (2016) pp. 423-427 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.512.046

More information

ANCA associated vasculitis in China

ANCA associated vasculitis in China ANCA associated vasculitis in China Min Chen Renal Division, Peking University First Hospital, Beijing 100034, P. R. China 1 General introduction of AAV in China Disease spectrum and ANCA type Clinical

More information

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SJÖGREN S SYNDROME: PREVALENCE AND CLINICAL SIGNIFICANCE

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SJÖGREN S SYNDROME: PREVALENCE AND CLINICAL SIGNIFICANCE British Journal of Rheumatology 1998;37:1287 1291 ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SJÖGREN S SYNDROME: PREVALENCE AND CLINICAL SIGNIFICANCE J. FONT, M. RAMOS-CASALS, R. CERVERA, X. BOSCH,

More information

The European and French networks. Christian Pagnoux, MD, MSc, MPH Mount Sinai Hospital, Toronto, Canada Cochin Hospital, Paris, France

The European and French networks. Christian Pagnoux, MD, MSc, MPH Mount Sinai Hospital, Toronto, Canada Cochin Hospital, Paris, France The European and French networks Christian Pagnoux, MD, MSc, MPH Mount Sinai Hospital, Toronto, Canada Cochin Hospital, Paris, France French Vasculitis Study Group December 1980: L. Guillevin no research,

More information

Diagnostic Procedures for Vasculitis

Diagnostic Procedures for Vasculitis Diagnostic Procedures for Vasculitis Toshiharu Matsumoto, MD Clinical Professor of Department of Diagnostic Pathology Juntendo University Nerima Hospital, Tokyo, Japan Introduction In 1994, the International

More information

Review Article. Introduction. Abstract. David Sinclair and Judith M Stevens

Review Article. Introduction. Abstract. David Sinclair and Judith M Stevens Review Article Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides David Sinclair and Judith M Stevens Abstract

More information

IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis

IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis Blackwell Science, LtdOxford, UKCEIClinical and Experimental Immunology0009-9104Blackwell Publishing Ltd, 2003 133 283289 Original Article Clin Exp Immunol 2003; 133:283 289 IgA class ANCA in PSC and AIHC.

More information

Case Report Testicular Vasculitis: A Sonographic and Pathologic Diagnosis

Case Report Testicular Vasculitis: A Sonographic and Pathologic Diagnosis Hindawi Case Reports in Radiology Volume 2017, Article ID 8923621, 4 pages https://doi.org/10.1155/2017/8923621 Case Report Testicular Vasculitis: A Sonographic and Pathologic Diagnosis Anuj Dixit, 1 Cameron

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

Case Report Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis

Case Report Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis Case Reports in Pathology, Article ID 286030, 5 pages http://dx.doi.org/10.1155/2014/286030 Case Report Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse

More information

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens: Autoimmunity Reactivity to self antigens: Autoreactivity: Autoimmune Disease T cells B cells Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection Epidemiology SLE Pathogenesis

More information

Increased levels of BLyS and svcam-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV)

Increased levels of BLyS and svcam-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV) Increased levels of BLyS and svcam-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV) C. Schneeweis 1,2, M. Rafalowicz 2, E. Feist 2, F. Buttgereit 2, P.-E. Rudolph 3, G.-R.

More information

MPO Test System. Rx Only 2Z9671G/SM2Z9671G

MPO Test System. Rx Only 2Z9671G/SM2Z9671G MPO Test System 2Z9671G/SM2Z9671G INTENDED USE The ZEUS ELISA Myeloperoxidase (MPO) Test System is intended for the qualitative and semi-quantitative detection of IgG-class antibody to myeloperoxidase

More information

Autoimmunity. Autoimmune Disease

Autoimmunity. Autoimmune Disease Autoimmunity Reactivity to self antigens: T cells B cells Autoimmune Disease Autoreactivity: Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection 1 SLE Pathogenesis Immune

More information

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis GLOMERULONEPHRITIDES Vivette D Agati Jai Radhakrishnan Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis Heavy Proteinuria Renal failure Low serum Albumin Hypertension

More information

The systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D.

The systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D. 60 Treatment of ANCA-associated Systemic Vasculitis H. Michael Belmont, M.D. Abstract The antineutrophil cytoplasmic antibodies (ANCA)-associated small vessel vasculitides include Wegener s granulomatosis,

More information

Clinical Laboratory. [None

Clinical Laboratory. [None Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Double-Stranded DNA (dsdna) Ab IgG ELISA Detected * [None 18-289-900151 Detected] Double-Stranded DNA (dsdna) Ab IgG

More information

Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features

Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features Kidney International, Vol. 57 (2000), pp. 846 862 PERSPECTIVES IN RENAL MEDICINE Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features JUDY SAVIGE,

More information

Supplementary Figure Legends

Supplementary Figure Legends Supplementary Figure Legends Supplementary Figure 1. Comparison of RNP IC-mediated NET formation. Quantification of DNA release induced by ICs consisting of SmRNP combined with SLE IgG 961 (n = 10), 1032

More information

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis Case Presentation VASCULITIS The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

ANCA Associated vasculitis presenting as bilateral pleural effusion: A rare case report

ANCA Associated vasculitis presenting as bilateral pleural effusion: A rare case report International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Case Report Volume 3, Issue 10-2017 DOI: http://dx.doi.org/10.22192/ijcrms.2017.03.10.015

More information

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects Clin Exp Immunol 1993; 91:1-12 REVIEW ANCA and associated diseases: immunodiagnostic and pathogenetic aspects W. L. GROSS, W. H. SCHMITT & E. CSERNOK Department of Clinical Rheumatology, Medical University

More information

tuberculosis,'0 and lung cancer." physicians. Wegener's granulomatosis (23%); of A Davenport, R J Lock, T B Wallington

tuberculosis,'0 and lung cancer. physicians. Wegener's granulomatosis (23%); of A Davenport, R J Lock, T B Wallington Thorax 994;49:3-7 Regional Immunology Service, Southmead Hospital, Westbury-on-Trym, Bristol BS NB, UK A Davenport R J Lock T B Wallington Reprint requests to: Dr A Davenport. Received 6 May 993 Returned

More information

Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody associated vasculitis

Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody associated vasculitis http://www.kidney-international.org & 212 International Society of Nephrology see commentary on page 16 Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody associated

More information

INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE

INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE Laboratory tests are an important adjunct in the clinical diagnosis of rheumatic diseases and are sometimes helpful in monitoring the activity of

More information

RENAL BIOPSIES in patients with the clinical

RENAL BIOPSIES in patients with the clinical RENAL BIOPSY TEACHING CASE Crescentic Glomerulonephritis With a Paucity of Glomerular Immunoglobulin Localization Alexis A. Harris, MD, Ronald J. Falk, MD, and J. Charles Jennette, MD RENAL BIOPSIES in

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Small Vessel Vasculitis Paul A Brogan Professor of Vasculitis and Consultant Paediatric Rheumatologist Department of Rheumatology Institute of Child Health and Great Ormond St Hospital, London UK P.brogan@ucl.ac.uk

More information

Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies

Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies Sinonasal involvement in systemic vasculitides and cocaine-induced midline destructive lesions: Diagnostic controversies M. Armengot, M.D., Ph.D., A. García-Lliberós, M.D., M. J. Gómez, M.D., A. Navarro,

More information

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward VASCULITIS SYNDROMES Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward ILLUSTRATED CASE 1 A 56 years old lady refered me for prolonged fever, arthritis

More information